Next-generation impactor for the pharmaceutical industry NGI

for aerodynamic particle size distribution

The Next Generation Impactor (NGI) is a high performance cascade impactor with seven stages. It is the standard used in USP guidelines. Product Details The NGI is and has been the industry standard pharmaceutical cascade impactor for the last 20 years, with 1800+ units in use and adopted into the USP guidelines. It was designed and developed by and for the OINDP Industry, and is the most efficient and accurate way to do standard in vitro APSD testing. There are many automated and semi-automated add-ons as well as other accessories designed to further improve efficiency. Applications Dry powder inhaler (DPI) testing Metered dose inhaler (MDI) testing Soft mist inhaler (SMI) testing Nebulizer testing Inhalation drug formulation development Respiratory drug delivery research Particle size distribution measurement in OINDPs Generic inhaler development Quality control for inhalation products Features and Benefits Approved by a Consortium of 15 Pharmaceutical Companies and FDA-accepted Precise cut points 8-stage collection (7 stage + MOC) Planar arrangement with cover, cup tray and quick clamp cam Suite of accessories to make testing even more efficient Suite of accessories for additional testing (stage bypass, morphological analysis, rNGI) Written into the USP guidance